MARIELLE MAHAN, MD
Ophthalmic Plastic and Reconstructive Surgery Physician in BETHESDA, Maryland. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
MARIELLE MAHAN, MD filed 290 Medicare Part D claims in 2023 as a Ophthalmic Plastic and Reconstructive Surgery Physician in BETHESDA, Maryland, prescribing 76% generic.
- 290
- Part D claims, 2023
- 76%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
MARIELLE MAHAN, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
290 49th percentile higher than 49% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
MARIELLE MAHAN, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about MARIELLE MAHAN, MD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Maryland
How Ophthalmic Plastic and Reconstructive Surgery Physician compares to other specialties among Maryland providers
Ophthalmic Plastic and Reconstructive Surgery Physician share within Maryland
Ophthalmic Plastic and Reconstructive Surgery Physician is one of the more visible NUCC categories in Maryland
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Ophthalmic Plastic and Reconstructive Surgery Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Ophthalmic Plastic and Reconstructive Surgery Physician ABMS/AOA estimate
Est. board-certified rate (Ophthalmic Plastic and Reconstructive Surgery Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Ophthalmic Plastic and Reconstructive Surgery Physician US NPIs
Specialty board-certified rate — Ophthalmic Plastic and Reconstructive Surgery Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MARIELLE MAHAN, MD appears in the CMS NPPES registry as a Ophthalmic Plastic and Reconstructive Surgery Physician provider holding MD credentials at 5612 SHIELDS DR, BETHESDA, MD, 20817, with a listed phone of (301) 571-4334. NPI 1487115010 was issued on 03/27/2019. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MAHAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 290 prescription claims written by this provider, covering 107 Medicare beneficiaries and totaling roughly $18K in drug spend, split 24% brand-name and 76% generic by claim count, with an opioid prescribing rate of 11.4%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Ophthalmic Plastic and Reconstructive Surgery Physician is a narrow specialty nationwide, with 291 enrolled providers across 46 states and an average of 624 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1487115010 |
|---|---|
| Specialty | Ophthalmic Plastic and Reconstructive Surgery Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 03/27/2019 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MARIELLE MAHAN, MD's current license status, disciplinary history, and board certifications with the Maryland Board of Physicians in Maryland before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where MARIELLE MAHAN, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Typical
24% brand-name claims vs 76% generic, on 290 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 349
- Total Day Supply
- 6,673
- Brand vs Generic
- 24% brand / 76% generic
- Brand Drug Cost
- $14K
- Generic Drug Cost
- $4K
- Opioid Claims
- 33 (11.4% rate)
- Antibiotic Claims
- 16
Patient Demographics
- Average Patient Age
- 73.8 years
- Avg HCC Risk Score
- 1.39
- Gender Split
- 68% female / 32% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What MARIELLE MAHAN, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
48 claims
- Ondansetron Odt
Ondansetron Odt
37 claims
- Prednisolone Acetate
Prednisolone Acetate
27 claims
- Hydrocodone-Acetam…
Hydrocodone-Acetaminophen
22 claims
- Methylprednisolone 18
Methylprednisolone
18 claims
- Dorzolamide-Timolol 15
Dorzolamide-Timolol
15 claims
- Neomycin-Polymyxin… 15
Neomycin-Polymyxin-Dexameth
15 claims
- Brimonidine Tartrate 13
Brimonidine Tartrate
13 claims
| Drug | Claims |
|---|---|
| Latanoprost | 48 |
| Ondansetron Odt Ondansetron | 37 |
| Prednisolone Acetate | 27 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 22 |
| Methylprednisolone | 18 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 15 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 15 |
| Brimonidine Tartrate | 13 |
| Rhopressa Netarsudil Mesylate | 13 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmic Plastic and Reconstructive Surgery Physician Overview
How MARIELLE MAHAN, MD fits within the Ophthalmic Plastic and Reconstructive Surgery Physician landscape nationally.
MARIELLE MAHAN, MD's 290 claims are below the specialty average of 624.
Nearby Ophthalmic Plastic and Reconstructive Surgery Physician Providers in Maryland
Other clinicians with the same primary specialty enrolled in Maryland, drawn from the same CMS NPPES roster as MAHAN.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Maryland
Frequently Asked Questions
What is MARIELLE MAHAN, MD's specialty? ▼
How much does MARIELLE MAHAN, MD prescribe under Medicare Part D? ▼
Where is MARIELLE MAHAN, MD located? ▼
What is MARIELLE MAHAN, MD's NPI number? ▼
Does MARIELLE MAHAN, MD prescribe more brand-name or generic drugs? ▼
Does MARIELLE MAHAN, MD prescribe opioids? ▼
How many Ophthalmic Plastic and Reconstructive Surgery Physician providers are there in the US? ▼
What drugs does MARIELLE MAHAN, MD prescribe most often? ▼
Does MARIELLE MAHAN, MD accept Medicare? ▼
How can I verify MARIELLE MAHAN, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology